Stallion India Expects FY28 Revenue to Exceed ₹1,100 Crore with 15% PAT Margin
Stallion India Fluorochemicals has outlined robust revenue and profitability guidance for FY28. Growth will be driven by the full operationalization of its new Helium, R-32, and Mambattu facilities, with management expecting group revenue to surpass ₹1,100 cr at an attractive 15% PAT margin. Although short-term project commissioning timelines led to a lower-than-anticipated Q4 FY27 estimate of ₹125 cr for the R-32 plant, the medium-term targets remain completely intact.
Market snapshot: Stallion India Fluorochemicals Limited (SIFL) has mapped out an ambitious road to scale, targeting FY28 revenues above ₹1,100 cr with a projected 15% PAT margin once its high-capacity plants are fully active. While the company adjusted near-term revenue projections for its R-32 plant in Q4 FY27 to ₹125 cr, long-term growth expectations for both the plant and the group remain strong.
Data Snapshot
- FY28 projected total revenue is guided to surpass ₹1,100 cr on full commissioning of three core expansion plants.
- The company expects an overall PAT margin of approximately 15% once its Helium, R-32, and Mambattu plants are fully running.
- R-32 plant Q4 FY27 revenue is estimated at ₹125 cr, down from a full-year forecast of ₹250 cr, though FY28 targets of ₹500-600 cr are intact.
What's Changed
- Q1 FY27 PAT rose to ₹18.57 cr, up 79.15% YoY from ₹10.36 cr in Q1 FY26, highlighting a massive operational scale-up before newer plants even go live.
- Near-term Q4 FY27 R-32 plant expectations were revised down to ₹125 cr (from an earlier ₹250 cr projection) due to calibrated project-execution timelines, shifting bulk revenue realization into FY28.
Key Takeaways
- Stallion India is successfully transitioning from a distribution-focused model to an integrated manufacturer.
- The mid-term revenue target of over ₹1,100 cr in FY28 outlines management's strategic confidence despite near-term adjustments.
- Calibrated capital deployment ensures that capacity expansion remains execution-linked rather than heavily front-loaded.
SAHI Perspective
Stallion India is systematically upgrading its structural margin profile. The upward adjustment of operating leverage—vividly captured in the 79.15% jump in Q1 FY27 profits—underscores the potential of its backward integration strategy. Although the R-32 plant's Q4 FY27 revenue estimate of ₹125 cr shows a near-term dip, keeping the FY28 target of ₹500-600 cr unchanged signals that long-term volume commitments from institutional buyers are stable.
Market Implications
The Indian fluorochemicals sector is currently moving through a multi-year expansion phase, fueled by domestic localization and high import barriers. Stallion's entry into high-purity Helium, R-32 refrigerants, and South Indian markets via Mambattu allows the company to capitalize directly on import substitution.
Trading Signals
Market Bias: Bullish
Strong operating results in Q1 FY27 paired with an intact long-term pipeline of over ₹1,100 cr in revenues by FY28 at a 15% PAT margin support a constructive outlook on the stock.
Overweight: Specialty Chemicals, Industrial Gases, Refrigerants
Trigger Factors:
- Successful commercial kickoff of the 1,200 MT high-purity helium processing unit at Khalapur in Q2 FY27.
- Commissioning of the Mambattu facility by the end of Q3 FY27 to build a strong footprint in South India.
- Execution and scaling of the Bhilwara R-32 plant to hit the ₹500-600 cr annual revenue target in FY28.
Time Horizon: Medium-term (3-12 months)
Industry Context
The global fluorochemicals landscape is seeing major demand from refrigeration, automotive, and semiconductor applications. SIFL's integration into Helium and semiconductor-grade gases places it in a highly lucrative, high-barrier niche, distinct from low-margin pure blenders.
Key Risks to Watch
- Project Commissioning Delays: Further schedule shifts in Mambattu or Bhilwara facilities could defer peak FY28 revenues.
- Sourcing Volatility: Margins are highly dependent on reliable sourcing of raw precursors like anhydrous hydrofluoric acid (AHF).
Recent Developments
Stallion India announced stellar financial results for Q1 FY27, with net profits (PAT) jumping 79.15% YoY to ₹18.57 cr, and EBITDA expanding 75.85% YoY to ₹25.27 cr on revenues of ₹124.68 cr. The company also prepared its 1,200 MT high-purity helium processing line at Khalapur, expected to commence commercial shipments in Q2 FY27.
Closing Insight
While minor adjustments in commissioning schedules have pushed some R-32 plant revenues out of FY27, SIFL's medium-term trajectory is firmly locked. Its transformation into a specialized, backward-integrated chemical giant makes it a powerful contender in India's industrial gas space.
High Performance Trading with SAHI.
Disclaimer: This news section may include AI-generated or AI-assisted news, summaries, drafts, or insights. All content is subject to human review before publication. While we aim for accuracy, readers should independently verify information before relying on it.
Open Free AccountRelated
JPMorgan Downgrades Apollo Tyres: Navigating Commodity Headwinds and Sector Re-rating
JPMorgan Bullish on TVS Motor: Target Price Hiked to ₹4,440 as Resilience Outshines Sector Risks
JPMorgan Shifts Stance on Escorts Kubota: Upgrade to Neutral Amid Sector Recalibration
Geopolitical Friction in Hormuz: Oil Majors Flag Costs of Proposed Tolls and India’s Readiness Gaps
Recent
Exicom Launches India's First Liquid-Cooled Charging Modules, Begins US Exports
Defence Acquisition Council Plans To Place ₹80,000 Crore Orders, Reports ET Now
Mamata Machinery Files Patent Application For Recyclable Film Technology Die and Screw Design
Refex Industries Wins ₹27.48 Crore Contract For Ash Transportation To NHAI Road Projects
Carysil Confirms US Tariff-Rate Quota On Quartz Surface Products Does Not Impact Quartz Sink Exports
Frequently Asked Questions (FAQs)
All topics
Click the link, confirm the box next to sahi.com is checked — ignore any other results.